Trial NCT05255666

View at ClinicalTrials.gov 
Org. Study IDs: 202111198

Last trial update was posted on 2023-07-11

MeSH Interventions

Irinotecan Pembrolizumab

MeSH Conditions

Brain Neoplasms Breast Neoplasms Neoplasm Metastasis Triple Negative Breast Neoplasms

Other Conditions

Brain Metastases Triple Negative Breast Cancer

Stopping Reasons

No drug

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID